The changing pattern of adherence to antiretroviral therapy assessed at two time points, 12 months apart, in a cohort of HIV-infected children

Expert Opinion on Pharmacotherapy

Volumn 10, Issue 17, 2009, Pages 2773-2778

  Giannattasio, Antonietta ^a   Albano, Fabio ^a   Giacomet, Vania ^b   Guarino, Alfredo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Adherence; Antiretroviral therapy; Children; HIV infection

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; STAVUDINE; ZIDOVUDINE;

ARTICLE; CAREGIVER; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PRESCHOOL CHILD; QUANTITATIVE ANALYSIS; SCHOOL CHILD; STRUCTURED INTERVIEW;

ANTI-HIV AGENTS; CHILD, PRESCHOOL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INFANT; MALE; PATIENT COMPLIANCE;

EID: 73249132461     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656560903376178     Document Type: Article

References (20)

1. Laurence J. Adhering to antiretroviral therapies. AIDS Patient Care STDS 2001;15:107-108
2. McNabb J, Ross JW, Abriola K, et al. Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic. Clin Infect Dis 2001;33:700-705
3. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30
4. Gibb DM, Goodall RL, Giacomet V, et al. Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial. Pediatr Infect Dis J 2003;22:56-62 (Pubitemid 36091779)
5. Guidelines for the use of antiretroviral agents in pediatric HIV infection. Available from: http://AIDSinfo.nih.gov [Last accessed 23 Feb 2009]
6. Amico KR, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr 2006;41:285-297
7. Simoni J, Pearson CR, Pantalone DW, et al. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load: a metaanalytic review of randomized controlled trials. J Acquir Immune Defic Syndr 2006;43:S23-35
8. Giacomet V, Albano F, Starace F, et al. Adherence to antiretroviral therapy and its determinants in children with human immunodeficiency virus infection: a multicentre, national study. Acta Paediatr 2003;92:1398-1402
9. Byakika-Tusiime J, Crane J, Oyugi JH, et al. Longitudinal antiretroviral adherence in HIV+ Ugandan parents and their children initiating HAART in the MTCT-Plus family treatment model: role of depression in declining adherence over time. AIDS Behav 2009;13:82-91
10. Davies MA, Boulle A, Fakir T, et al. Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study. BMC Pediatr 2008;8-34:1-12
11. Van Dyke RB, Lee S, Johnson GM, et al. Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection. Pediatrics 2002;109:e61 Furthermore, an association between full adherence to treatment and maintenance of viral suppression was reported.
12. Albano F, Giacomet V, De Marco G, et al. Adherence to antiretroviral therapy in children: a comparative evaluation of caregiver reports and physician judgment. AIDS Care 2007;19:764-766
13. Merzel C, Vandevanter N, Irvine M. Adherence to antiretroviral therapy among older children and adolescents with HIV: a qualitative study of psychosocial contexts. AIDS Patient Care STDS 2008;22:977-987
14. Mellins CA, Brackis-Cott E, Dolezal C, Abrams EJ. The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. Pediatr Infect Dis J 2004;23:1035-1041 These results underline that special efforts addressing psychosocial and family factors are required to improve child adherence to HAART.
15. Wrubel J, Moskowitz JT, Richards TA, et al. Pediatric adherence: perspectives of mothers of children with HIV. Soc Sci Med 2005;61:2423-2433
16. Billups SJ, Malone DC, Carter BL. The relationship between drug therapy non-compliance and patient characteristics, health-related quality of life, and health care costs. Pharmacotherapy 2000;20:941-949
17. Sharkness CM, Snow DA. The patient's view of hypertension and compliance. Am J Prev Med 1992;8:141-146
18. Wagner GJ, Rabkin JG. Measuring medication adherence: are missed doses reported more accurately then perfect adherence? AIDS Care 2000;12:405-408
19. Miller LG, Hays RD. Adherence to combination antiretroviral therapy: synthesis of the literature and clinical implications. AIDS Read 2000;10:177-185
20. Shalansky SJ, Levy AR. Effect of number of medications on cardiovascular therapy adherence. Ann Pharmacother 2002;36:1532-1539